As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...